Navigation Links
Clinical Conductor CTMS Takes Aim at Optimizing Oncology Clinical Trials
Date:10/15/2014

Rochester, NY (PRWEB) October 15, 2014

The team behind Clinical Conductor is proud to announce brand new enhancements to the industry-leading CTMS. This first oncology focused release of several in the coming quarters adds a multitude of advanced features and functionalities designed to optimize the management and execution of oncology studies at organizations of all sizes and makeups.

While clinical trial management systems (CTMS) offer oncology-based solutions, Clinical Conductor is the only CTMS to build oncology-specific functionality directly into a robust, already-existing CTMS workflow. The resulting outcome allows organizations to successfully run complex oncology studies while also maximizing profitability and achieving high quality clinical research results.

The first major advancement in the latest release of Clinical Conductor CTMS is adaptive and dynamic protocol design. These features let organizations have precise control and understanding of the varying patient protocols within the same study. Organizations will also be able to move patients between different arms of the same study more easily, create patient visit cycles and build varying procedures by study.

Billing compliance functionality within Clinical Conductor has also been enhanced, allowing organizations managing and executing oncology studies to create multiple versions of cost-allocation grids for multi-arm trials, providing more accurate billing information with less time and effort. Also, Clinical Conductor’s financial tools accommodate complex and changing protocols, allowing organizations to effectively bill for recurring visits and other complexities that result from oncology protocol design. In addition to this, organizations can set specific Medicare coverage designations at specific sites.

Clinical Conductor CTMS also contains National Cancer Institute (“NCI”) reporting functionality. This added functionality allows organizations to reduce the time spent tracking information necessary for NCI Data Tables 3 and 4 NCI, by allowing staff to compile NCI-specific information directly within Clinical Conductor. This functionality creates NCI-compliant reports and allows researchers to adhere to NCI grant requirements more easily.

“The latest release of Clinical Conductor delivers market-leading functionality for organizations running complex oncology trials, enabling them to not only implement protocols of ever increasing complexity but do so within an environment of enhanced efficiency and profitability,” stated VP and COO Jeff Markin, “In the coming months we plan to release further oncology directed enhancements, furthering our leadership in providing the most comprehensive CTMS in the industry for organizations running complex clinical research.”

The addition of new oncology capabilities within Clinical Conductor CTMS is set to make a very positive impact on the oncology and complex research communities, as Clinical Conductor CTMS use expands into four of the largest health systems in the US, and many other academic medical centers and healthcare organizations around the world.

About Clinical Conductor
Clinical Conductor is the industry’s first collaborative and configurable CTMS for organizations managing or executing clinical trials. Created by Bio-Optronics, an industry-leading provider of software and services to healthcare and life sciences organizations around the world, Clinical Conductor is designed to provide users with the specific features and functionality they need to effectively collaborate with or among sites and other partners, deliver high-quality research and attain maximum profitability. Used by over 1,700 organizations around the world, Clinical Conductor provides organizations with the tools they need to continue to raise the bar in clinical research. To learn more about Clinical Conductor CTMS, please visit our website.

Read the full story at http://www.prweb.com/releases/2014/10/prweb12248080.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Nashville is Site of National Conference and Pediatric Intensive Focusing on Clinical Aspects of Hospice and Palliative Care
2. University of Calgary research leads to brain cancer clinical trial
3. Shareable Ink to Provide Simplified Clinical Documentation Solutions for Allscripts Sunrise Clients
4. Clinical Laboratory Services Market By Test (Human & Tumor Genetics, Clinical Chemistry), By Service Provider (Hospitals) Is Expected To Reach USD 261.42 Billion By 2020
5. Unstable Angina Therapeutics Clinical Trials Market Review Report Available at MarketOptimizer.org
6. Ventricular Septal Defect Therapeutics Clinical Trials Market Review Report Available at MarketOptimizer.org
7. Vascular Calcification Therapeutics Clinical Trials Market Review Report Available at MarketOptimizer.org
8. Global Intermittent Claudication Clinical Trials Market Review 2014 in a New Report Available at MarketOptimizer.org
9. New Article Urges Mesothelioma Patients to Take Part in Clinical Trials, According to Surviving Mesothelioma
10. US aims for traumatic brain injury clinical trial success
11. AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2019)... CHICAGO (PRWEB) , ... July 12, 2019 , ... The ... Industry Report. This report is designed to help medical aesthetic and medical spa professionals ... collected from providers across the industry. , “It’s been two years since AmSpa released ...
(Date:7/12/2019)... (PRWEB) , ... July 12, 2019 , ... Rebecca Baxt, ... approved by NJ Top Docs for 2019. Located in Paramus, BAXT CosMedical is a ... state-of-the-art cosmetic and medical dermatological care for the past 45 years. , NJ Top ...
(Date:7/11/2019)... (PRWEB) , ... July 11, 2019 , ... ... new knowledge tools and educational resources with a range of features to further ... across the global pharmaceutical industry in manufacturing quality medicines for patients worldwide. The ...
(Date:7/10/2019)... ... ... Foggiare --the first and only U.S. company to offer Slim-Up treatments--is now ... by Sauna Italia , an Italian manufacturer of advanced aesthetic and wellness equipment, ... locations in Europe and Asia. Slim-Up is scientifically proven to be effective in smoothing ...
(Date:7/10/2019)... ... , ... HMP, a leader in healthcare events and education, today announced the ... taking place October 11-13, 2019 in Boston. , Launched in 2016, the Congress is ... of clinical pathways as a decision support tool and their increasing influence on patient ...
Breaking Medicine News(10 mins):
(Date:7/17/2019)... ... ... Steven C. Bilt, Chief Executive Officer of Smile Brands Inc. spoke about ... during a panel discussion at Dykema’s 6th Annual Definitive Conference for Dental Service Organizations ... Dallas, Texas. , Bilt co-founded Smile Brands Inc. in 1998 and has been instrumental ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... As part ... Medical Center has added the Medtronic O-arm® Mobile Surgical Imaging System to lessen ... Director of The Minimally Invasive Brain and Spine Center at Mercy has ...
(Date:7/13/2019)... AUSTIN, Texas (PRWEB) , ... July 12, 2019 ... ... 3.5 million Americans’ ability to communicate and socialize with others. Given how widespread ... know someone on the spectrum! While autism cannot be “cured,” there are treatment ...
Breaking Medicine Technology: